Figure 3.
G-CSF increased the number of MSCs in BLM-treated lungs and promoted BMSC homing to lung tissues. (A) FCM gating strategy for the surface expression of CD31-CD34-CD29+CD44+Sca-1+ cells from mouse lungs. (B) The number of CD31-CD34-CD29+CD44+Sca-1+ cells in the lungs was analysed by FCM. (C) Identification of BMSCs in mice by FCM. Representative flow cytometric analysis of BMSCs isolated from the bone marrow and stained with antibodies against CD29, CD31, CD34, CD44 and Sca-1. (D) Representative FCM analysis of the GFP-labelled BMSC population. GFP-labelled BMSCs were infused into mice, and after 36 hours, the lungs were prepared into a single-cell suspension and analysed by FCM. (E) Data analysis of the GFP-labelled BMSC population tested by FCM. Control (BMSC) and BLM (BMSC) represent conditions where BMSCs were not pretreated before being infused into control or BLM mice, whereas control (G-CSF > BMSC) and BLM (G-CSF > BMSC) represent conditions where BMSCs were pretreated with G-CSF (30 ng/mL) before being infused into control or BLM mice. n = 3–5. *P < 0.05, **P < 0.01 between the indicated groups. Bars: mean ± SD.